Williams & Connolly client Medtronic won dismissal of a putative securities class action suit where plaintiffs asserted purported violations of Sections 10(b) and 20A of the Exchange Act, alleging that an action taken by a regulator and a related disclosure rendered certain statements regarding future product approvals false and misleading. In March 2024, the U.S. District Court for the District of Minnesota granted Medtronic’s motion to dismiss, but allowed plaintiffs to replead. On September 30, 2025, following oral argument by partner Amanda M. MacDonald, the court again granted Medtronic’s motion to dismiss, dismissing plaintiffs’ claims in their entirety, this time with prejudice. The court held that even as amended, the complaint failed to allege any actionable false or misleading statements.
In addition to Ms. MacDonald, the Williams & Connolly team included associates Jamie Wolfe and Aden MacMillan.
Click here to read Law360’s coverage of the matter.